Warfarin and bevacizumab suppress tumor progression in pancreatic ductal adenocarcinoma by targeting EGFR-PI3K-Akt signaling: inhibition of proliferation/migration and apoptosis induction.

Transl Cancer Res · 2025 · PMC12776193 · PMID 41510069

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP > 0.05actually significant

In contrast, the BE group exhibited a modest increase (10.92%±1.11%) that did not reach statistical significance (P > 0.05), indicating a limited pro-apoptotic effect.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.